2024 ICD-10-CM Diagnosis Code T50.Z13S
Poisoning by immunoglobulin, assault, sequela
- ICD-10-CM Code:
- T50.Z13S
- ICD-10 Code for:
- Poisoning by immunoglobulin, assault, sequela
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
T50.Z13S is a billable diagnosis code used to specify a medical diagnosis of poisoning by immunoglobulin, assault, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T50.Z13S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like poisoning by immunoglobulin assault. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Excessive dose of antiserum administered
- Excessive dose of gamma globulin administered
- Intentional excessive dose of antiserum administered
- Intentional excessive dose of gamma globulin administered
Clinical Classification
Clinical Category is Poisoning/toxic effect/adverse effects/underdosing, sequela
- CCSR Category Code: INJ075
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
Diphtheria
a localized infection of mucous membranes or skin caused by toxigenic strains of corynebacterium diphtheriae. it is characterized by the presence of a pseudomembrane at the site of infection. diphtheria toxin, produced by c. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.Diphtheria Antitoxin
an antitoxin produced against the toxin of corynebacterium diphtheriae that is used for the treatment of diphtheria.Diphtheria Toxin
an adp-ribosylating polypeptide produced by corynebacterium diphtheriae that causes the signs and symptoms of diphtheria. it can be broken into two unequal domains: the smaller, catalytic a domain is the lethal moiety and contains mono(adp-ribose) transferases which transfers adp ribose to peptide elongation factor 2 thereby inhibiting protein synthesis; and the larger b domain that is needed for entry into cells.Diphtheria Toxoid
the formaldehyde-inactivated toxin of corynebacterium diphtheriae. it is generally used in mixtures with tetanus toxoid and pertussis vaccine; (dtp); or with tetanus toxoid alone (dt for pediatric use and td, which contains 5- to 10-fold less diphtheria toxoid, for other use). diphtheria toxoid is used for the prevention of diphtheria; diphtheria antitoxin is for treatment.Diphtheria-Tetanus Vaccine
a combined vaccine used to prevent infection with diphtheria and tetanus toxoid. this is used in place of dtp vaccine (diphtheria-tetanus-pertussis vaccine) when pertussis vaccine is contraindicated.Diphtheria-Tetanus-acellular Pertussis Vaccines
combined vaccines consisting of diphtheria toxoid; tetanus toxoid; and an acellular form of pertussis vaccine. at least five different purified antigens of b. pertussis have been used in various combinations in these vaccines.Diphtheria-Tetanus-Pertussis Vaccine
a vaccine consisting of diphtheria toxoid; tetanus toxoid; and whole-cell pertussis vaccine. the vaccine protects against diphtheria, tetanus, and whooping cough.Fowlpox
a poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts.Heparin-binding EGF-like Growth Factor
an egf family member that is expressed in a variety of hematopoietic, endothelial, vascular smooth muscle, and epithelial cells. it is synthesized as a transmembrane protein which is cleaved by proteases to produce the secreted form of the protein which has specificity for the egf receptor and the erbb-4 receptor. the membrane-bound form of the protein has been identified as the receptor which binds to and allows diphtheria toxin to enter cells.Hepatitis B
inflammation of the liver in humans caused by a member of the orthohepadnavirus genus, hepatitis b virus. it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.Hepatitis B Antibodies
antibodies to the hepatitis b antigens, including antibodies to the surface (australia) and core of the dane particle and those to the "e" antigens.Hepatitis B Antigens
antigens of the virion of the hepatitis b virus or the dane particle, its surface (hepatitis b surface antigens), core (hepatitis b core antigens), and other associated antigens, including the hepatitis b e antigens.Hepatitis B Core Antigens
the hepatitis b antigen within the core of the dane particle, the infectious hepatitis virion.Hepatitis B e Antigens
a closely related group of antigens found in the plasma only during the infective phase of hepatitis b or in virulent chronic hepatitis b, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins g.Hepatitis B Surface Antigens
those hepatitis b antigens found on the surface of the dane particle and on the 20 nm spherical and tubular particles. several subspecificities of the surface antigen are known. these were formerly called the australia antigen.Hepatitis B Vaccines
vaccines or candidate vaccines containing inactivated hepatitis b or some of its component antigens and designed to prevent hepatitis b. some vaccines may be recombinantly produced.Hepatitis B virus
the type species of the genus orthohepadnavirus which causes human hepatitis b and is also apparently a causal agent in human hepatocellular carcinoma. the dane particle is an intact hepatitis virion, named after its discoverer. non-infectious spherical and tubular particles are also seen in the serum.Hepatitis B Virus, Duck
a dna virus that closely resembles human hepatitis b virus. it has been recovered from naturally infected ducks.Hepatitis B Virus, Woodchuck
an orthohepadnavirus causing chronic liver disease and hepatocellular carcinoma in woodchucks. it closely resembles the human hepatitis b virus.Hepatitis B, Chronic
inflammation of the liver in humans caused by hepatitis b virus lasting six months or more. it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.Orthohepadnavirus
a genus of hepadnaviridae causing hepatitis in humans, woodchucks (hepatitis b virus, woodchuck) and ground squirrels. hepatitis b virus is the type species.Rabies
acute viral cns infection affecting mammals, including humans. it is caused by rabies virus and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf.Rabies Vaccines
vaccines or candidate vaccines used to prevent and treat rabies. the inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.Rabies virus
the type species of lyssavirus causing rabies in humans and other animals. transmission is mostly by animal bites through saliva. the virus is neurotropic multiplying in neurons and myotubes of vertebrates.
Coding Guidelines
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Present on Admission (POA)
T50.Z13S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert T50.Z13S to ICD-9-CM
- ICD-9-CM Code: 909.0 - Late eff drug poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment. - ICD-9-CM Code: E969 - Late effect assault
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
Table of Drugs and Chemicals
The parent code T50.Z13 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Poisoning
A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:
- Prescription or over-the-counter medicines taken in doses that are too high
- Overdoses of illegal drugs
- Carbon monoxide from gas appliances
- Household products, such as laundry powder or furniture polish
- Pesticides
- Indoor or outdoor plants
- Metals such as lead and mercury
The effects of poisoning range from short-term illness to brain damage, coma, and death. To prevent poisoning it is important to use and store products exactly as their labels say. Keep dangerous products where children can't get to them. Treatment for poisoning depends on the type of poison. If you suspect someone has been poisoned, call your local poison control center at 1-800-222-1222 right away.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.